One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.

Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction. 

New research, published in The American Journal of Cardiology, uncovers widespread variability in provider preference for image guidance during PCI. 

Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

New research suggests the technique can effectively break down amyloid fibrinogen microclots, which are believed to interfere with perfusion and cause inflammation.

The photoacoustic CT, or PACT, imaging technique is said to perform comparably to mammography for cancer detection, but without the discomfort of standard mammograms.